FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11961811000001106: Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
43585501000001113 Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105860901000001113 Rasilez 300mg tablets (Noden Pharma DAC) 28 tablet 4 x 7 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Aliskiren hemifumarate true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Is a Aliskiren 300mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Is pack of Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has active ingredient Aliskiren false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has AMP Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Aliskiren false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Aliskiren hemifumarate false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance Aliskiren true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start